Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENALAPRIL for Malignant hypertension: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where ENALAPRIL was used for Malignant hypertension.

Most Reported Side Effects for ENALAPRIL

Side Effect Reports % Deaths Hosp.
Acute kidney injury 916 11.9% 87 670
Drug ineffective 599 7.8% 20 214
Hypotension 556 7.2% 42 386
Dyspnoea 514 6.7% 22 281
Hypertension 451 5.8% 4 136
Hyperkalaemia 448 5.8% 35 317
Drug interaction 441 5.7% 26 264
Angioedema 412 5.3% 15 251
Off label use 347 4.5% 21 154
Diarrhoea 342 4.4% 34 183
Nausea 342 4.4% 8 183
Hyponatraemia 341 4.4% 12 269
Cough 323 4.2% 3 127
Dizziness 308 4.0% 11 179
Malaise 302 3.9% 9 155

Other Indications for ENALAPRIL

Hypertension (2,892) Product used for unknown indication (2,486) Cardiac failure (451) Cardiac failure chronic (141) Essential hypertension (68) Cardiac failure congestive (66) Proteinuria (58) Blood pressure abnormal (48) Cardiac disorder (41) Blood pressure measurement (39)

Other Drugs Used for Malignant hypertension

ALISKIREN HEMIFUMARATE (22) AMLODIPINE (14) CLEVIDIPINE (11) CLONIDINE (10) OLMESARTAN MEDOXOMIL (8) METOPROLOL (7) NICARDIPINE (7) PRAZOSIN (7) AZILSARTAN KAMEDOXOMIL\CHLORTHALIDONE (6) HYDRALAZINE (6)

Related Pages

ENALAPRIL Full Profile All Malignant hypertension Drugs ENALAPRIL Demographics ENALAPRIL Timeline